Diacomit,司替戊醇,斯利潘托

Stiripentol

Another Name
Diacomit,司替戊醇,斯利潘托
Indications
suitable for treating epileptic seizures
Reg No
12 L 1053/23
Inspection No
3178-23
dosage form:Capsules
Specs:250mg*60pills
Indate:24 months
Date：2024-9-1 Views：1023
Drug Info

COMPOSITION:

Each LuciStir capsule contains Stiripentol……………………………. 250 mg

INDICATION:

LuciStir is indicated for the treatment of seizures associated with Dravet syndrome (DS) in patients taking clobazam who are 6 months of age and older and weighing 7 kg or more.

DOSAGE AND USE:

The dosage of LuciStir is 50 mg/kg/day, depending on age and weight.

• Capsules must be swallowed whole with a glass of water during a meal. Capsules should not be broken or opened.

• Reduce dose or discontinue dose gradually.

STORAGE:

In a dry place and store at 20°C to 25°C.

MANUFACTURED AND MARKETED BY:

LUCIUS PHARMACEUTICALS(LAO) CO., LTD

No.26, Thongmang village, Xaythany district, Vientiane Capital, Laos

WARNING:

Keep medicine out of reach of Children. Do not administer LuciStir during Pregnancy and Lactation.

Original article, if reprinted, please indicate the link to this article: https://lucius-pharmaceuticals.com/drug/stiripentol/

Related News